
Pazonat 200mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Pazopanib (200mg)
Overview Pazonat 200mg Tablet
Kinase-inhibiting Pazonat 200mg tablets are indicated for kidney cancer and soft tissue sarcoma. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician, depending on your condition and may be adjusted. Strictly adhere to prescribed instructions; incorrect usage or overdose can have severe consequences. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common adverse reactions include elevated blood pressure and diarrhea; the former requires regular monitoring, while the latter can be managed with increased hydration or medical consultation. Pazonat may lower blood cell counts, increasing infection risk. Report fever, flu-like symptoms, or breathlessness immediately. Prior to commencing treatment, inform your doctor of any existing heart, liver, or kidney conditions, and all medications, particularly anti-infectives, as significant interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Pazonat 200mg Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Pazonat 200mg Tablet
Renal cell carcinoma or soft tissue sarcoma.
Major Benefits of Pazonat 200mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 200mg Pazonat tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Pazonat 200mg Tablet:
- Headache
- Nausea
- Vomiting
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Change in color of hair
- Diarrhea
- High blood pressure
- Decreased appetite
- Weight loss
- Taste change
- Abnormal skin pigmentation
- Hair discoloration
- Tumor pain
- Breathlessness
How to use Pazonat 200mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 200mg Pazonat tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Pazonat 200mg Tablet works:
Pazonat 200mg tablets function as an anti-neoplastic agent. Its mechanism involves targeted inhibition of tyrosine kinase enzyme receptors, thereby curbing cancerous cell multiplication. Additionally, it suppresses angiogenesis, limiting tumor vascularization and growth. This dual action underlies its anti-cancer efficacy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Pazonat 200mg Tablet may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Pazonat 200mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation and Pazonat 200mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking a Pazonat 200mg Tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Pazonat 200mg tablets can be safely administered to individuals with renal impairment. No alteration of the Pazonat 200mg tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should exercise caution when using Pazonat 200mg tablets, potentially requiring dosage modification under medical supervision. Pazonat 200mg tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Pazonat 200mg Tablet :
NA
Facts to Know About Pazonat 200mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Diarylalkylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
